|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
ATE459373T1
(de)
|
1999-03-19 |
2010-03-15 |
Glaxosmithkline Biolog Sa |
Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
|
|
ATE512666T1
(de)
|
1999-06-29 |
2011-07-15 |
Epimmune Inc |
Hla-bindende peptide und ihre verwendungen
|
|
FR2798128B1
(fr)
|
1999-09-06 |
2001-11-16 |
Inst Nat Sante Rech Med |
Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla
|
|
WO2001058479A1
(en)
|
2000-02-08 |
2001-08-16 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
CA2400215A1
(en)
|
2000-02-23 |
2001-08-30 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US7892559B2
(en)
*
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
WO2003092717A1
(en)
|
2002-03-22 |
2003-11-13 |
The Penn State Research Foundation |
Cancer immunotherapy
|
|
CA2500715A1
(en)
|
2002-10-03 |
2004-04-15 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
CN1954217B
(zh)
|
2004-02-06 |
2013-05-08 |
国立健康与医学研究所 |
衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
|
|
US7612162B2
(en)
|
2004-09-21 |
2009-11-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
BRPI0720280A2
(pt)
|
2006-12-11 |
2014-01-28 |
Wyeth Corp |
Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13
|
|
US8569244B2
(en)
*
|
2007-08-20 |
2013-10-29 |
Oncotherapy Science, Inc. |
FOXM1 peptide and medicinal agent comprising the same
|
|
ES2532896T5
(es)
|
2008-05-14 |
2018-03-20 |
Immatics Biotechnologies Gmbh |
Péptidos del MHC de clase II novedosos y potentes derivados de survivina y neurocan
|
|
WO2010018136A1
(en)
|
2008-08-12 |
2010-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers
|
|
RS53782B1
(sr)
*
|
2008-10-01 |
2015-06-30 |
Immatics Biotechnologies Gmbh |
Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
WO2010129033A2
(en)
|
2009-04-29 |
2010-11-11 |
Calmune Corporation |
Modified antibodies for passive immunotherapy
|
|
KR101276180B1
(ko)
*
|
2009-11-03 |
2013-06-18 |
고려대학교 산학협력단 |
산화아연-결합성 펩타이드를 포함하는 단백질과 산화아연 나노입자의 복합체 및 그의 용도
|
|
GB201004575D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
CA2809362C
(en)
|
2010-08-24 |
2020-03-10 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Educatn |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
WO2013101690A1
(en)
|
2011-12-29 |
2013-07-04 |
modeRNA Therapeutics |
Modified mrnas encoding cell-penetrating polypeptides
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
EP2828664B1
(en)
|
2012-03-19 |
2018-09-26 |
Stemline Therapeutics Inc. |
Methods for treating and monitoring the status of cancer
|
|
WO2013148147A1
(en)
|
2012-03-26 |
2013-10-03 |
The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services |
Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
CA3183703A1
(en)
|
2012-05-16 |
2013-11-21 |
Stemline Therapeutics, Inc. |
Cancer stem cell targeted cancer vaccines
|
|
US20140141044A1
(en)
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
US9758807B2
(en)
|
2012-12-05 |
2017-09-12 |
SOLA Biosciences, LLC |
Protein expression enhancing polypeptides
|
|
WO2014088432A1
(en)
|
2012-12-06 |
2014-06-12 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
GB201315946D0
(en)
*
|
2013-09-06 |
2013-10-23 |
Immune Targeting Systems Its Ltd |
Oncology vaccine
|
|
SG10202005892SA
(en)
*
|
2014-06-06 |
2020-07-29 |
Herlev Hospital |
Determining antigen recognition through barcoding of mhc multimers
|
|
US20180133327A1
(en)
|
2015-03-16 |
2018-05-17 |
Amal Therapeutics Sa |
Cell Penetrating Peptides and Complexes Comprising the Same
|
|
US20180078627A1
(en)
|
2015-03-31 |
2018-03-22 |
Agency For Science, Technology And Research |
Method for antigen loading of dendritic cells and vaccine
|
|
BR112018005581A2
(pt)
|
2015-10-08 |
2018-10-16 |
Oncotherapy Science, Inc. |
peptídeo derivado de foxm1 e vacina incluindo o mesmo
|
|
US12018331B2
(en)
|
2016-05-23 |
2024-06-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
WO2018065623A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Immunogenic compounds for cancer therapy
|
|
CN110022894B
(zh)
|
2016-10-07 |
2024-01-19 |
恩特罗姆公司 |
用于癌症疗法的免疫原性化合物
|
|
WO2018065628A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
KR102823291B1
(ko)
|
2017-10-09 |
2025-06-19 |
엔터롬 에스.에이. |
종양-관련된 항원 에피토프의 미생물 서열 변이체
|
|
US20210106652A1
(en)
|
2018-04-11 |
2021-04-15 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
|
|
MX2022004598A
(es)
|
2019-10-16 |
2022-09-23 |
Enterome S A |
Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
|
|
FI4021487T3
(fi)
|
2019-11-15 |
2024-02-06 |
Enterome S A |
Antigeenisiä peptidejä b-solun pahanlaatuisuuden ehkäisyyn ja hoitoon
|